A review of psychoactive medication in cancer care describes a balance between avoidable exposure and undertreated psychological distress.
What the source reports
Ten observational studies from low- and middle-income settings addressed antidepressants, benzodiazepines, Z-drugs, and antipsychotics. Prescribing varied with comorbidity, age, medication burden, insurance, and geography. The authors described potentially inappropriate benzodiazepine use alongside underdiagnosis and undertreatment of mental-health conditions.
Limits and uncertainty
The review did not find studies from low-income countries, despite its broad intended scope. Heterogeneous observational reports cannot establish comparative drug effectiveness or a universal appropriate prescribing rate. Recorded use also does not fully capture patients’ experiences or treatment goals.
Implications for forensic review
For a cancer-care opinion, low prescribing is not automatically good care and high prescribing is not automatically poor care. Assess the specific indication, symptom burden, alternatives, response, and safety review. The paper supports examining access and appropriateness together rather than drawing conclusions from prescription counts alone.
Source and related reading
Source reviewed: Prescription and use of psychoactive medications among cancer patients and associated factors in low (PMC12769504). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: Mental-Health-Ward Deprescribing Interviews Identified an Interface Problem; Psychiatric Driving Review Found That Treatment Stage Matters.
Leave a Reply